header image

News

Octapharma present new data on the benefits of Nuwiq® in patients with haemophilia A at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress

08.07.2019

Octapharma announced today that new data on the benefits of Nuwiq® in patients with haemophilia A were presented during a scientific symposium at the 27th International Society on Thrombosis and Haemostasis (ISTH) Congress in...

Octapharma to Present New Data on Management of People with Haemophilia A or von Willebrand Disease at ISTH 2019

02.07.2019

New scientific data on Octapharma’s Haematology portfolio will be presented at the upcoming 27th Congress of the International Society on Thrombosis and Haemostasis (ISTH), taking place in Melbourne, Australia, from 6 to 10 July...

Octapharma Group reports strong results for 2018

14.03.2019

Reporting revenue of €1.8 billion and operating income of €346 millionGroup sales increased 4.5% compared to 2017 (on a constant currency basis, the growth rate is 6.6%)All our products performed well, but to be highlighted are...